Cryoprecipitate, also called "cryoprecipitated antihaemophilic factor", "cryoprecipitated AHF", and "cryo" for short, is a frozen blood product prepared from plasma. To acquire cryoprecipitate, the fresh frozen plasma should be centrifuged and the precipitate should be collected.

It is often transfused as a four to six unit pool instead of as a single product. Many uses of the product have been replaced by factor concentrates, but it is still routinely stocked by many hospital blood banks.

Unlike fresh frozen plasma, compatibility testing is not strictly necessary, but cryo is given as ABO compatible when possible. (Compatibility is reversed for plasma products: O- type is the universal plasma recipient and AB+ type is the universal plasma donor.)


Each unit (around 10 to 15 mL) typically provides:[1]

Cryoprecipitate also contains fibronectin; however there are no clear indications for fibronectin replacement.

US standards require manufacturers to test at least four units each month, and the products must have an average of 150 mg or more of fibrinogen and 80 IU of factor VIII.[2] Individual products may actually have less than these amounts as long as the average remains above these minimums. Typical values for a unit are substantially higher, and aside from infants it is rare to transfuse just one unit.


Indications for giving cryoprecipitate include:[3]

Adverse effects

Adverse effects reported with the usage of cryoprecipitate include hemolytic transfusion reactions, febrile non-hemolytic reactions, allergic reactions (ranging from urticaria to anaphylaxis), septic reactions, transfusion related acute lung injury, circulatory overload, transfusion-associated graft-versus-host disease, and post-transfusion purpura.[4]


  1. "CRYO (cryoprecipitate) pharmacology". Medscape.
  2. "Circular of Information For the Use of Human Blood and Blood Components" (PDF). Archived from the original (PDF) on 2008-02-27. Retrieved 2008-02-28.
  3. Erber WN, Perry DJ (2006). "Plasma and plasma products in the treatment of massive haemorrhage". Best Pract Res Clin Haematol. 19 (1): 97–112. doi:10.1016/j.beha.2005.01.026. PMID 16377544.
  4. "CRYO (cryoprecipitate) Adverse Effects". Medscape.
This article is issued from Wikipedia - version of the 12/3/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.